Sign in Register

Drug class

Opioid Analgesics- ER (with all antitussive opiates)

The phrase "Opioid Analgesics- ER (with all antitussive opiates)" is an administrative drug-compendium and clinical decision support grouping rather than a recognized formal therapeutic class defined by the FDA. Read more about Opioid Analgesics- ER (with all antitussive opiates)

161 drugs in this class 82 manufacturers

Advertisement

Related classes & indications

Antipsychotics, AtypicalCNS, pain & psychiatry · 296 prescription drugs Antidepressant Serotonin-Norepinephrine Reuptake Inh.(SNRIs)CNS, pain & psychiatry · 127 prescription drugs PainTop indication · 657 prescription drugs

Drugs in Opioid Analgesics- ER (with all antitussive opiates)

Showing 154–161 of 161 drugs

BUTRANS (buprenorphine)

OPIOID ANALGESICS- ER (WITH ALL ANTITUSSIVE OPIATES) · SEVERE CHRONIC PAIN REQUIRING LONG-TERM OPIOID TREATMENT
KNOA PHARMA LLC

BUPRENORPHINE

OPIOID ANALGESICS- ER (WITH ALL ANTITUSSIVE OPIATES) · SEVERE CHRONIC PAIN REQUIRING LONG-TERM OPIOID TREATMENT
RHODES PHARMA L

MS CONTIN (morphine sulfate)

OPIOID ANALGESICS- ER (WITH ALL ANTITUSSIVE OPIATES) · SEVERE CHRONIC PAIN REQUIRING LONG-TERM OPIOID TREATMENT
RHODES PHARMA L

METHADONE HCL

AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID WITHDRAWAL SYMPTOMS ·+2
AHP
Filter & compare in the drug finder → Opens the drug finder with Opioid Analgesics- ER (with all antitussive opiates) preselected. Add indication or manufacturer filters there.

About Opioid Analgesics- ER (with all antitussive opiates).

The phrase "Opioid Analgesics- ER (with all antitussive opiates)" is an administrative drug-compendium and clinical decision support grouping rather than a recognized formal therapeutic class defined by the FDA.

Functionally, this category encompasses extended-release opioid agonists, along with opioid-based antitussive agents, which primarily act by binding to central nervous system mu-opioid receptors to inhibit ascending pain pathways and suppress medullary cough centers.

In clinical practice, the extended-release analgesic formulations in this group are indicated for severe chronic pain requiring continuous, round-the-clock opioid therapy when alternative treatments prove inadequate, while the associated antitussive agents are used for the symptomatic suppression of nonproductive cough.